Helmholtz Gemeinschaft


Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus

Item Type:Article
Title:Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus
Creators Name:Pecher, G. and Spahn, G. and Schirrmann, T. and Kulbe, H. and Ziegner, M. and Schenk, J.A. and Sandig, V.
Abstract:Background: Dendritic cells (DC) as antigen presenting cells play an important role in immunotherapy of cancer. Mucin, encoded by the gene MUC1, is a human tumor antigen expressed in breast, pancreatic and ovarian cancers. Therefore, MUC1-transfected DC would be an attractive tool in constructing cancer vaccines. Materials and Methods: Using two different cationic liposome preparations and, for comparison, a recombinant adenovirus expressing mucin, we tested the efficiency of mucin gene transfer into DC by flow cytometry. We investigated if these transfected DC were able to specifically stimulate autologous peripheral blood lymphocytes (PBL) from healthy donors. Results: Flow cytometry revealed that 5-20% of DC transfected with liposomes Lipofectin® and 20-40% of DC transduced with adenovirus expressed the relevant mucin epitopes. The expression of mucin on DC was similar to the expression of mucin found on carcinoma cells. After antigen uptake, DC specifically stimulated autologous PBL. Conclusion: We have shown that cationic liposomal gene transfer into human DC was feasible. We could obtain antigen specific stimulation of PBL at a similar rate as with adenoviral MUC1-transduced DC.
Keywords:Adenovirus, Cationic Liposomes, Dendritic Cells, Gene Transfer, Mucin (MUC1)
Source:Anticancer Research
Page Range:2591-2596
Date:1 January 2001
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library